Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

INTRODUCTION: A new type of immune cell transplantation called allogeneic NK cell infusion is proposed as a potential universal off-the-shelf cell product for adoptive immune cell therapy in hematologic malignancies. DESIGN: A multicentral phase I non-randomized clinical trial was conducted to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadvand, Mohammad, Barough, Mahdieh Shokrollahi, Barkhordar, Maryam, Faridfar, Ali, Ghaderi, Afshin, Jalaeikhoo, Hasan, Rajaienejad, Mohsen, Majidzadeh, Keivan, Ghavamzadeh, Ardeshir, Sarrami-Forooshani, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636850/
https://www.ncbi.nlm.nih.gov/pubmed/37950209
http://dx.doi.org/10.1186/s12885-023-11610-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636850/
https://www.ncbi.nlm.nih.gov/pubmed/37950209
http://dx.doi.org/10.1186/s12885-023-11610-x

Ejemplares similares